Na V 1.1 is the primary voltage-gated Na + channel in several classes of GABAergic interneurons, and its reduced activity leads to reduced excitability and decreased GABAergic tone. Here, we show that Na V 1.1 channels are expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus. Mice carrying a heterozygous loss of function mutation in the Scn1a gene (Scn1a +/− ), which encodes the pore-forming α-subunit of the Na V 1.1 channel, have longer circadian period than WT mice and lack light-induced phase shifts. In contrast, Scn1a ). Enhancement of GABAergic transmission with tiagabine plus clonazepam partially rescues the effects of deletion of Na V 1.1 on circadian period and phase shifting. Our report demonstrates that a specific voltage-gated Na + channel and its associated impairment of SCN interneuronal communication lead to major deficits in the function of the master circadian pacemaker. Heterozygous loss of Na V 1.1 channels is the underlying cause for severe myoclonic epilepsy of infancy; the circadian deficits that we report may contribute to sleep disorders in severe myoclonic epilepsy of infancy patients. entrainment | neuronal oscillators | sodium channel T he mammalian suprachiasmatic nucleus (SCN) of the hypothalamus houses a master circadian clock that governs phase coordination between peripheral oscillators and overt circadian rhythms (1) as well as synchronization of these rhythms to the light-dark (LD) cycle through the retinohypothalamic tract (RHT) (2). Although SCN neurons are autonomous single-cell oscillators that rely on autoregulatory transcriptional/translational feedback loops of clock genes (3, 4), interneuronal synchronization is critical for the SCN to act as a tissue pacemaker with a coherent output (5, 6). Sodium-dependent action potentials are known to be essential for the synchronization between clock neurons in the SCN as well as necessary to maintain robust oscillations of clock gene expression (ref. 7 and reviewed in ref. 6), but the molecular identity of voltage-gated Na + channels contributing to the synchronization of the SCN neuronal network is currently unknown.
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Over 90% of SCN neurons contain GABA as a neurotransmitter and express GABA A and GABA B receptors (8) (9) (10) , and electrophysiological and pharmacological studies in vitro have pointed to GABA as a key signal mediating SCN neuronal network properties (11, 12) . Studies of mutant mice show that voltage-gated sodium channel type 1 (Na V 1.1) encoded by the Scn1a gene is the primary voltage-gated Na + channel in several classes of GABAergic interneurons (13, 14) . Scn1a +/− mice are a genetic model for a devastating form of epilepsy, severe myoclonic epilepsy of infancy (SMEI) (15) (16) (17) . Loss of firing of GABAergic neurons and the resulting disinhibition of neural circuits are hypothesized to be the underlying cause of epilepsy and comorbid ataxia in this disease (13, 14, 18) . Homozygous Scn1a −/− mice are more severely impaired and die on postnatal day 15 (P15) (13) .
We reasoned that impairment of action potential firing and intercellular communication between SCN neurons may disrupt the function of the master circadian clock within the SCN, and therefore, our mouse model of SMEI may provide a unique opportunity to further define the role of Na V 1.1 channels and GABAergic neurotransmission in the SCN using a genetic approach. We report that Scn1a +/− mice have a severe disruption of their circadian system that is consistent with dramatic impairments in intercellular signaling in the SCN and can be partially rescued by pharmacological enhancement of GABAergic transmission. Our results give important insight into the critical role of the Na V 1.1 channel and GABAergic neurotransmission within the mammalian master circadian clock. In addition, these findings support the hypothesis that reduced excitability of the GABAergic neurons of the SCN contributes to the sleep impairment in SMEI patients.
Results
Expression of Na V 1.1 Channels in the SCN. We first examined expression of the Na V 1.1 channel in SCN neurons using in situ hybridization in brain sections from WT, Scn1a +/− , and Scn1a −/− mice (13) . Digoxigenin-labeled antisense oligonucleotides complementary to Na V 1.1 mRNA showed strong labeling in SCN neurons of WT mice but not homozygote mutant mice (Fig. 1A) . Immunoblotting detected the Na V 1.1 protein in SCN tissue as a 250-kDa band with intensity that was reduced to approximately one-half of WT levels in heterozygotes [mean Scn1a +/− /WT expression ratio for four experiments was 0.46; 95% confidence interval (CI) = 0.02, 0.90] and nearly zero in homozygotes (Fig.  1B) . Expression of Na V 1.1 channels within SCN neurons is not surprising given that this particular voltage-gated Na + channel plays a primary role in action potential firing in GABAergic interneurons (13) , where it is expressed specifically within the neuronal soma (19) , and the vast majority of SCN neurons are GABAergic (8, 9) . As in previous studies (13, 14) , we confirmed the expression of the Na V 1.1 channel within GABAergic cells (Fig. 1C) . Cells expressing Na V 1.1 mRNA were more abundant within the ventral SCN, where GABAergic cells are densely packed (8) , and Na V 1.1 expression was colocalized with immunostaining for glutamate decarboxylase (GAD), a rate-limiting enzyme for GABA synthesis (Fig. 1C) . The number of total DAPI-stained cells did not differ between Scn1a −/− and WT animals (two-tailed Student t test, P = 0.85, n = 4 per genotype), suggesting that the mutation causes no major anatomical changes in the SCN.
Circadian Behavioral Phenotypes in Scn1a
+/− Mice. To assess the role of Na V 1.1 channels in circadian behavior, we studied runningwheel activity in Scn1a +/− and WT mice. Both genotypes entrained to a 12:12 (LD) cycle, although the phase of activity onset of Scn1a +/− mice under LD conditions was delayed relative to the phase of WT mice (Fig. 2 A, C , and E and Fig. S1 ). On transfer of animals into constant darkness (DD), Scn1a +/− mice showed a free-running period significantly longer than the WT period (24.28 ± 0.11 vs. 23.74 ± 0.03 h, respectively; P = 0.0004, two-tailed Student t test) (Fig. 2 A, B , and D) and significantly longer than 24 h (95% CI = 24.02, 24.54).
The overall activity of Scn1a +/− mice was greatly reduced compared with WT mice under both LD and DD light conditions (Fig. 2E) . The normalized activity profile during the dark phase was also distinct; WT mice were more active at the beginning of night, whereas Scn1a +/− mice were more active at the end of the night, showing a delayed activity bout (Fig. 2E) . Overall, the amplitude of circadian locomotor activity rhythm was reduced in Scn1a +/− mice. Importantly, this finding was the result of both reduced activity levels during the subjective night (Fig. 2E ) and higher activity levels during the subjective day. Of note, increased activity during the subjective day also indicates that the mild ataxic phenotype of Scn1a +/− mice (13) does not impair their ability to display higher levels of wheel-running activity than WT mice.
We examined the response of rhythmic locomotor activity in Scn1a +/− mice to a phase-shifting light pulse. A brief light pulse applied during the early subjective night is associated with a delay in the circadian pacemaker (20) (21) (22) . WT mice showed a 2.8 h mean phase delay in wheel-running activity in response to a 30-min, 500-lux light pulse applied at circadian time 16 (CT16, with CT12 corresponding to the onset of locomotor activity) ( Fig. 3 A  and B ). This delay was statistically different from zero (95% CI = −4.8, −0.8). In contrast, Scn1a +/− mice failed to respond to the same light treatment (Fig. 3 A and B) (mean = 0.4 h, 95% C = −1.4, 2.2). +/− animals exhibit lower levels of activity under DD (Left) and LD (Center) conditions. During the dark phase, their activity onset is delayed relative to the WT activity onset (Right). Waveforms in Left and Center include 18 successive days for 9 WT (black circles) and 10 Scn1a +/− (white circles) mice; then, the mean ± SEM was calculated from all of the animals for each 30-min interval. Right shows the same data as in Center normalized to the maximum activity level for the 24-h period.
Impairment in photic phase resetting in Scn1a
+/− mice was also evident after exposing animals to abrupt phase shifts of the LD cycle. After a 6-h delay, it took 8.6 ± 0.5 d for Scn1a +/− mice to fully reentrain compared with 2.7 ± 0.2 d for WT (Fig. 3 C and  D) . This slow reentrainment of Scn1a +/− mice was also evident for advances of the LD cycle (10.2 ± 1.1 d for Scn1a +/− mice; 5.7 ± 0.9 d for WT mice) ( Fig. 3 C and D) . A two-way ANOVA revealed an effect of genotype (P < 0.0001) and an effect of the shift type (delay vs. advance, P = 0.01) but no effect of the interaction (P = 0.34). Thus, Scn1a +/− mice have impaired circadian photoresponsiveness, which is evident as a lack of response to nocturnal light pulses and a significantly slower reentrainment after abrupt phase shifts mimicking jetlag.
Scn1a
+/− Mice Show Exaggerated Negative Masking Behavior and Normal Electroretinography. As shown in Fig. 3 , Scn1a +/− mice failed to respond to a phase-resetting light pulse during the early subjective night and showed a significantly impaired response to abrupt phase shifts of the LD cycle. This overall impairment of circadian photoresponsiveness could reflect a failure of the retina to relay light information to the SCN. To test this hypothesis, we examined the ability of light to inhibit nocturnal wheel running, known as negative masking (23) , a response that is usually associated with normal photoentrainment of circadian rhythms (2) . We delivered a 4-h light pulse of different intensity during the early night [Zeitgeber time (ZT) 15 to ZT19, with ZT12 being the time of lights off) and measured the percent inhibition of wheel-running activity relative to the activity at the same time on the following day when light was not presented during the night (Fig. 4A) . As expected, WT mice showed moderate positive masking (increased wheel-running activity) under dim (2 lux) red light and negative masking that was progressively stronger with increasing white light intensity (Fig. 4B) . Remarkably, Scn1a +/− mice did not show positive masking under 2-lux red light; instead, their activity was inhibited significantly more than in WT animals under the same intensity. Furthermore, Scn1a +/− mice showed stronger negative masking across light intensities (Fig. 4 A and B) [two-way ANOVA, significant effect of light intensity (P < 0.0001), genotype (P < 0.0001), and interaction (P < 0.0001)].
We also measured electroretinography (ERG) for Scn1a
and WT mice to test for a possible retinal abnormality. Analysis of electroretinograms showed no significant difference in the a-wave amplitude (two-tailed Student t test, P = 0.26), b-wave amplitude (two-tailed Student t test, P = 0.26), or a-wave width (WT, 18.44 ± 0.63; Scn1a +/− , 17.5 ± 1.42; two-tailed Student t test, P = 0.56) between the two genotypes ( Fig. 4 C and D) . Thus, we found no evidence for a defect in the outer retina that could explain the paradoxical presence of increased negative masking-a form of nonimage-forming photoreception that is usually affected in parallel to circadian photoreception-and the failure of light to induce phase shifts in Scn1a +/− mice.
Clock Gene Expression Pattern in Scn1a
+/− Mice. Autoregulatory transcriptional/translational feedback loops of clock genes constitute the molecular clockwork of single-cell circadian oscillators (4). Abnormal circadian rhythmicity in Scn1a +/− mice could be caused by altered clock gene expression within the SCN. The expression of the clock genes Per1 and Per2 oscillates with a peak during the day or subjective day; the peak of Per2 mRNA slightly lags the peak of Per1 (24-26). We examined the circadian expression pattern of Per1 and Per2 mRNA by in situ hybridization in WT and Scn1a +/− brain slices from animals killed every 4 h after at least 24 h under DD. Per1 mRNA was rhythmic for both genotypes, with a peak between CT4 and CT8 ( Fig. 5 A and B) . A two-way ANOVA yielded a significant effect of time (P < 0.0001), genotype (P = 0.035), and interaction (P = 0.001). The mRNA levels oscillated with slightly lower amplitude in Scn1a +/− than WT mice. Per2 expression levels also followed a similar circadian expression pattern but with an approximate 4-h delay relative to Per1 (Fig. 5 C  and D) . A two-way ANOVA revealed no effect of genotype (P = 0.16) but a significant effect of time (P < 0.0001) and interaction (P = 0.04), which was also a consequence of a slightly lower amplitude oscillation in Scn1a +/− mice. Thus, although the expression of both clock genes oscillates with the normal phase in Scn1a +/− animals that received a 30-min, 500-lux light pulse starting at CT16 (white circle) and showed a delay or no response, respectively. (B) Light pulses at CT16 induced delays in WT but not Scn1a +/− mice. Values represent mean ± SEM for control dark-and light-pulsed animals. *Only group that showed a mean shift with 95% CI that did not include zero (n = 4 and 5 for WT control and light pulse, respectively; n = 5 and 8 for Scn1a
+/− mice exhibit slower reentrainment to abrupt phase shifts of the LD cycle than WT mice. Representative actograms of WT and Scn1a +/− animals exposed to an abrupt 6-h advance and later, to an abrupt 6-h delay. (D) The number of days to achieve full reentrainment is longer for Scn1a +/− than WT mice both for delays and advances (n = 6 and 6 for WT mice for advances and delays, respectively; n = 12 and 10 for Scn1a +/− mice). Values represent mean ± SEM. *Statistically different from WT mice (two-way ANOVA, significant effect of genotype, P < 0.0001).
creased negative masking of their nocturnal activity and suggest that the failure of light pulses to induce phase shifts during the subjective night may reflect an inability of the SCN to decode retinal afferent input. Photic information to the circadian system is relayed by retinal ganglion cells that innervate the SCN through the RHT (2). In the mouse, RHT fibers innervate predominantly the ventral SCN, and light pulses during the subjective night, but not during the subjective day, acutely induce the expression of the immediate-early gene c-Fos and the clock gene Per1 (27, 28) . This induction of gene expression takes place initially within the ventral SCN and later propagates to the dorsal SCN (28) (29) (30) (31) (32) . Because the photic induction of both behavioral phase shifts and Per1 expression is restricted to the night, the acute induction of clock gene expression by light is thought to be critical for phase resetting of the clock. We therefore examined the light-induced gene expression pattern in WT and Scn1a +/− mice. Animals maintained under DD were killed 0, 15, 30, 60, and 90 min after the onset of a 30-min, 500-lux light pulse that started at CT16. Brains were collected and SCN slices were processed for in situ hybridization for c-Fos or Per1 mRNA. Fig.  6A shows that c-Fos expression was initiated early (15 min) after the light pulse, reached a peak at 30 min, and decreased thereafter in both WT and Scn1a +/− SCN. Light-induced expression of c-Fos initially started in the ventral SCN with moderately higher levels in WT animals ( Fig. 6 A and B) [two-way ANOVA, significant effect of genotype (P < 0.0001), time (P < 0.0001), and interaction (P = 0.02)]. In Scn1a +/− SCN, c-Fos expression was more confined to the ventral SCN, and its propagation to the dorsal SCN was much less prominent 30 min after the onset of the light pulse ( Fig. 6 A and B) [two-way ANOVA, significant effect of genotype (P < 0.0001), time (P < 0.0001), and interaction (P = 0.0001)].
The increase in Per1 expression was more gradual than the increase in c-Fos expression. Within the ventral SCN, the increase of Per1 mRNA was similar between WT and Scn1a +/− mice ( Fig. 6 C and D) [two-way ANOVA, no effect of genotype (P = 0.13) and a significant effect of time (P < 0.0001) and interaction (P = 0.03)], with reduced expression in Scn1a +/− animals only after 60 min. In contrast to the expression of Per1 in the ventral SCN, its expression was substantially decreased in the dorsal SCN of Scn1a +/− mice ( Fig. 6 C and D) [two-way ANOVA, significant effect of genotype (P = 0.0001), time (P < 0.0001), and interaction (P = 0.0006)], with significantly lower expression levels than in WT mice for every time point after light stimulation. Thus, the analysis of light-induced expression of +/− animals show that the levels of Per1 oscillate in mice of both genotypes with the same phase but with lower amplitude in Scn1a +/− mice. Values represent mean ± SEM. Two-way ANOVA: significant effect of time (P < 0.0001), genotype (P = 0.035), and interaction (P = 0.001). *Significant difference between genotypes for that specific time point (Student t test contrasts, P = 0.05). (C and D) Same as in A and B, but sections were hybridized with an antisense radiolabeled probe against Per2 mRNA. Two-way ANOVA: no effect of genotype (P = 0.16) but significant effect of time (P < 0.0001) and interaction (P = 0.04). Rectangles on values in B and D label CT0 values that are replotted for easier visualization of the oscillation. For B and D, n is at least six animals per genotype and time point. 2+ ] i , and these increases are dependent on the occurrence of postsynaptic action potentials (35) . Na V 1.1 is the primary sodium channel in the cell bodies of several classes of GABAergic interneurons, and its reduced activity results in decreased excitability of these cells after postsynaptic depolarization (13, 14) . We reasoned that this reduced excitability could lead to smaller increases in [Ca 2+ ] i within ventral SCN neurons and reduced propagation of the signal into dorsal neurons after RHT stimulation. We incubated coronal SCN slices from WT, Scn1a +/− , and Scn1a −/− P14 mice with the membrane-permeable calcium indicator dye fluo-4/AM, which allows monitoring of single-cell activity simultaneously in multiple neurons. RHT stimulation of WT SCN slices with stimulation frequencies within the physiological range of firing of retinal ganglion cells that innervate the SCN (36) (0.1-20 Hz) led to increased [Ca 2+ ] i in SCN neurons that was dependent on stimulation frequency as previously reported (35) (Fig. 7 A and  B) . These increases occurred first in ventral SCN neurons and later, with lower amplitude, in dorsal cells (Fig. 7 C and D) . Whereas in WT SCN, 10-Hz stimulation resulted in robust increases of [Ca 2+ ] i in both ventral and dorsal SCN neurons, these increases were reduced to 50% and 30% of WT values in Scn1a +/− and Scn1a −/− mice, respectively ( Fig. 7 C and D) . The peak intensity ratios of the dorsal over ventral [Ca 2+ ] i increases in the Scn1a +/− and Scn1a −/− were significantly lower than the ratio of WT (Fig. 7E) [one-way ANOVA, significant effect of genotype (P = 0.01)]. A two-way ANOVA of the latency of cells to show peak fluorescence revealed a significant effect of genotype (P = 0.0024) and region (P = 0.04) and no effect of the +/− animals killed at different times after the onset of a 30-min, 500-lux light pulse starting at CT16 (time 0) and hybridized with an antisense radiolabeled probe against c-Fos mRNA. (B) Relative c-Fos mRNA expression within the ventral and dorsal SCNs at different times after light pulse onset. Two-way ANOVA for ventral: significant effect of genotype (P < 0.0001), time (P < 0.0001), and interaction (P = 0.02). Two-way ANOVA for dorsal: significant effect of genotype (P < 0.0001), time (P < 0.0001), and interaction (P = 0.0001). (C and D) Same as A and B, but sections were hybridized with an antisense radiolabeled probe against Per1 mRNA. Two-way ANOVA for ventral: no effect of genotype (P = 0.13) but significant effect of time (P < 0.0001) and interaction (P = 0.03). Two-way ANOVA for dorsal: significant effect of genotype (P = 0.0001), time (P < 0.0001), and interaction (P = 0.0006). For B and D, n = 6 per genotype and time point. *Statistically significant difference between genotypes (Student t test contrasts, P = 0.05). ] i increase between cells in each region is reduced in Scn1a +/− and KO mice. # Main effect of genotype (P = 0.01, one-way ANOVA). *Significantly different from WT (Tukey contrasts, P = 0.05); n = 6 for WT, n = 4 for Scn1a +/− , and n = 4 for Scn1a −/− mice.
interaction (P = 0.15), with an increased latency for Scn1a
and Scn1a +/− cells compared with WT cells (Tukey contrasts, P = 0.05). These data, along with our in situ hybridization data, indicate that the signal transmission between ventral and dorsal SCNs in the Scn1a +/− and Scn1a −/− is significantly reduced as a consequence of loss of Na V 1.1 activity.
Treatment with Drugs That Enhance GABAergic Neurotransmission Partially Rescues the Circadian Phenotype of Scn1a
+/− Mice. In Fig. 1 , we show that the Na V 1.1 channels are expressed in the GABAcontaining SCN neurons. Furthermore, reduced Na V 1.1 activity is known to drastically reduce the excitability of GABAergic interneurons in both the hippocampus (13) and cerebellum (14) . Therefore, we hypothesized that the circadian phenotype in the Scn1a +/− mice may be caused by reduced GABAergic transmission as a consequence of decreased Na V 1.1 activity in the SCN. To test this hypothesis, we treated mice with tiagabine, a GABA reuptake blocker (2.5 mg/kg), and clonazepam, an allosteric modulator of the GABA A receptor (1 mg/kg) by adding both drugs to the rodent diet (BIO-SERV). These food doses result in ∼0.4 and 0.16 mg/kg adult body weight per day of tiagabine and clonazepam, respectively (37) . We provided the GABAergic transmission-enhancing drugs from P1 by supplying the food pellets to lactating mothers. Animals treated with this drug combination throughout their lifespan and untreated control animals were tested by measurement of wheel-running activity. Drug treatment had no effect on WT mice but significantly rescued the impaired circadian behavior of Scn1a +/− mice (Fig. 8) . The long circadian period of Scn1a +/− mice (τ = 24.05 ± 0.02 h) was significantly shortened (τ = 23.8 ± 0.05 h, P = 0.01) (Fig. 8C) . Light-induced phase delays in the Scn1a +/− mice were also significantly increased from −0.11 ± 0.036 to −1.37 ± 0.21 h (P = 0.05) (Fig. 8D) . Drug treatment led to a rescue of circadian amplitude as well, which was evident as increased nocturnal activity and decreased diurnal activity (Fig. 8 B, E, and F) . The drug-increased nocturnal activity in Scn1a +/− mice was bimodal and had a different profile than the activity of WT animals (compare Fig. 8B with Fig. 2E) . A two-way ANOVA for light phase activity led to a significant effect of genotype (P = 0.0009), drug treatment (P = 0.0036), and interaction (P = 0.0019), and planned least-squares comparisons showed that GABAergic transmission enhancement decreased diurnal activity in Scn1a +/− but not WT mice (Fig. 8F) . A two-way ANOVA for dark phase activity led to a significant effect of genotype (P < 0.0001), no effect of drug treatment (P = 0.17), and a significant effect of interaction (P = 0.017); planned least-squares comparisons showed that GABAergic transmission enhancement increased nocturnal activity in Scn1a +/− but not WT mice (Fig. 8E) . Importantly, the doses of tiagabine and clonazepam used do not induce sedative effects, which is consistent with the increased nocturnal activity that we observed in drug-treated Scn1a +/− mice. Taken together, these data show that the circadian abnormality of Scn1a +/− mice is, at least in large part, because of the decreased GABAergic transmission in the SCN as a consequence of decreased Na V 1.1 channel function.
Discussion
Our results show that heterozygous loss-of-function mutation of the Na V 1.1 channel in mice leads to major circadian abnormalities, including a longer circadian period, decreased circadian amplitude, delayed activity onset, and severely impaired circadian photoresponsiveness compared with WT mice. Our study +/− mouse and an Scn1a +/− mouse treated with a mixture of tiagabine (2.5 mg/kg) and clonazepam (1 mg/kg) (drug) under DD and then exposed to a light pulse at CT16 (white circle). (B) GABAergic transmission enhancement rescues nocturnal activity levels and the distribution of nocturnal activity to a more consolidated onset at the time of lights off. It also decreases diurnal activity. Waveforms include 18 successive days for four drug-treated (black circles) and three control (white circles) Scn1a +/− mice; then, the mean ± SEM was plotted from all of the animals for each 10-min interval. (C) Drug treatment shortens the period of Scn1a +/− mice but not WT mice. *Significantly different from control (P = 0.01, two-tailed Student t test; n = 5 for each WT group, n = 3 for control mice, and n = 4 for drug-treated Scn1a +/− mice). (D) Drug treatment rescues the inability of Scn1a +/− mice to show phase delays in response to light pulse at CT16. *Groups that showed a mean shift with 95% CI that did not include zero (n = 5 for each WT group, n = 3 for control mice, n = 4 for drug-treated Scn1a +/− ). (E and F) Drug treatment increases nocturnal activity and decreases diurnal activity in Scn1a +/− mice but not WT mice. Bars represent the 12-h (day or night) mean ± SEM of running-wheel activity during 20 d. *Significantly different from control (planned least-squares comparisons, P = 0.02 for night and P = 0.0003 for day).
# Significantly different from WT control (planned least-squares comparisons, P < 0.0001 for night and day); n = 5 for both WT groups, n = 3 for control group, and n = 4 for drug-treated Scn1a +/− group.
assessed the effect of the reduced activity of a specific voltagegated Na + channel in the SCN neuronal network. The significant recovery of all circadian defects in Scn1a +/− mice by GABAergic transmission-enhancing drugs points to decreased GABAergic transmission within the SCN-because of reduced Na V 1.1 channel activity-as the main cause for this disrupted circadian phenotype.
Although an increase of the WT period by 0.5 h in Scn1a +/− mice seems moderate, it is remarkable for a heterozygous mutation of a nonclock gene, because changes of comparable magnitude are observed in heterozygous mutations of core clock components, such as the gene Clock (38) . Furthermore, a change from a circadian period shorter than 24 h to one longer than 24 h has dramatic effects on the phase angle of entrainment (21); thus, the longer circadian period of Scn1a +/− mice is predictive of the delay of several hours in their locomotor activity, which is clearly the case in Scn1a +/− mice. Children with SMEI have impaired sleep-wake cycles, including delayed sleep onset and difficulty maintaining sleep (39) . The delayed phase of entrainment may, in part, explain delayed sleep onset in SMEI patients, because a delayed phase would push the time of sleep onset to a later time in the day. A similar effect of a change in circadian period, although in the opposite direction, seems to be responsible for familial advanced sleep phase syndrome (40, 41) .
The circadian oscillation in clock gene expression that we report in Scn1a +/− mice has moderately lower amplitude than the oscillation in WT mice, suggesting that a lower-amplitude master circadian clock is, in part, responsible for their lower amplitude behavioral rhythm. The difficulty to maintain sleep reported in SMEI patients could, in part, emerge from a lower circadian amplitude oscillator that fails to sustain sleep during the night and/or wakefulness during the day.
Scn1a
+/− Mice Have Impaired Function of Their Master Circadian
Clock. The widespread expression of Na V 1.1 channels in SCN neurons and the extent of impairment of clock function in Scn1a +/− mice point to a critical role of Na V 1.1 channels in the mammalian master circadian clock. The heterozygous Scn1a +/− mice have a circadian period that is significantly longer than the WT period and also longer than 24 h. Their activity during subjective night is markedly shifted to the end of the dark period. Remarkably, they have completely lost the ability to shift the phase of their circadian clock in response to a strong delaying light pulse, and their resynchronization speed after an abrupt shift in the LD cycle is profoundly reduced. Altogether, these deficits, and particularly, the changes in circadian period, indicate that reduced Na V 1.1 activity directly impairs SCN function.
Recent studies have shown that the long photoperiod scattering of circadian phases of single-cell neuronal oscillators in the SCN is associated with a low-amplitude electrical activity rhythm in the SCN tissue as a whole (42, 43) , suggesting that the lower amplitude circadian rhythms in Scn1a +/− mice may result from uncoupling of SCN neurons caused by reduced Na V 1.1 channel activity. If this suggestion is the case, the reduced amplitude of Per1 and Per2 expression in Scn1a +/− mice may reflect a population of neurons that are oscillating with scattered phases rather than a reduction of clock gene oscillation amplitude within each cell. This interpretation is consistent with the finding that TTX applied to hypothalamic slices blocks SCN action potentials but does not affect the circadian oscillation of clock genes (44), although longer-term TTX blockade may interfere with clock gene expression (7) . Similarly, circadian clock gene expression does not seem to be impaired in animals with reduced delayed rectifier potassium currents (45) or aged animals (46) , both of which show low-amplitude circadian rhythms. Finally, decreased amplitude of circadian locomotor activity could also result from the reduced Na V 1.1 channel activity in brain regions outside of the SCN.
The lack of light-induced phase shift in Scn1a +/− mice is likely caused at the level of the SCN, because there is no deficit in light-induced negative masking or the ability of light to induce clock gene expression within the ventral SCN. Although reduced photic phase shifting would not be predicted for a low-amplitude oscillator (21) , recent studies have shown that scattering of the phases of single-cell neuronal oscillators in the SCN results both in low-amplitude circadian rhythms and reduced phase-shifting ability (42) . Thus, our results suggest that reduced Na V 1.1 activity within the SCN neuronal network may account for both the low amplitude circadian rhythms and a reduced ability to respond to phase-shifting light stimuli. Our negative masking experiments show that Scn1a +/− mice are more sensitive to light than WT mice. Genetic mutations that affect retinal sensitivity usually cause both reduced light-induced phase shifts and diminished negative masking (47, 48) . Our results show that circadian photoresponsiveness and negative masking can be affected in opposite directions in an animal with intact retinal photoreception. Although our study does not exclude a retinal abnormality in layers other than the outer retina in Scn1a +/− mice (e.g., intrinsically photoreceptive ganglion cells) (2), our data suggest that photic inhibition of locomotor activity in mice is not decoded by the SCN or alternatively, that photic input to the ventral SCN is sufficient to induce this inhibition. Revealing the substrates for the exaggerated negative masking in Scn1a +/− mice may be important to understand the neural bases of hyperphotosensitivity and light-induced seizures in SMEI patients (49) . Emergent properties of the SCN neuronal network are known to be critical to produce a coherent and robust circadian output (reviewed in refs. 5 and 50). Nonspecific blockade of voltagegated Na + channels with TTX desynchronizes Per1 expression rhythms in individual SCN neurons in vitro (7). Furthermore, mathematical models clearly show that changes in coupling in a multioscillator system like the SCN can lead to changes in the emergent period of the network (51, 52) , which is the case in vasoactive intestinal polypeptide (VIP) KOs; they can show periods longer or shorter than the WT period (53) . Together, these findings are consistent with the altered circadian period that results from lower Na V 1.1 activity.
As previously reported (28, 54) , light-induced expression of Per1 in WT mice is initially restricted to the ventral SCN and later propagates to the dorsal SCN. Whereas Scn1a +/− mice showed relatively normal light-induced expression of Per1 and c-Fos in the ventral SCN, expression of both genes was substantially reduced in the dorsal SCN. Furthermore, reduced Na V 1.1 expression leads to reduced Ca 2+ transients in the ventral and particularly, the dorsal SCN in response to RHT stimulation. [Ca 2+ ] i increases in SCN neurons are proportional to the postsynaptic action potential frequency after excitatory postsynaptic potentials that result from RHT stimulation, but they are absent if these excitatory postsynaptic potentials fail to induce action potentials (35) . Expression of both c-Fos and Per1 within SCN cells is regulated by [Ca 2+ ] i (55) and action potential frequency (56) . Therefore, it is likely that action potentials generated by Na V 1.1 channels, which are primarily localized within neuronal cell bodies and axonal hillock (19) (5, 11, 50, (57) (58) (59) . The partial rescue of the lengthened circadian period and light-induced phase shifts in Scn1a +/− mice by GABAergic transmission-enhancing drugs is consistent with a critical role of SCN GABAergic transmission in period determination and decoding of photic information. This latter role has been previously suggested by electrophysiological studies in rat brain slices using GABA A receptor antagonists, which block the ability of the ventral SCN to relay photic information to the dorsal SCN (12) . Our study supports this role using both in vitro and in vivo assays in a transgenic animal model that leads to decreased GABAergic transmission. Furthermore, the pharmacological rescue of circadian abnormalities in Scn1a
+/− mice that we report relies on drugs that are not GABA A receptor agonists or antagonists; instead, they enhance the effect of endogenously released GABA on this receptor.
Although GABA is predominantly an inhibitory neurotransmitter throughout the adult CNS, several studies have indicated that it can either inhibit or excite SCN neurons, and the ratio of excited/inhibited cells changes throughout the circadian cycle (12, 57, (60) (61) (62) . During the circadian night, when light can phase shift the clock, a higher proportion of neurons is excited by GABA and RHT stimulation (61) . After stimulation of the RHT during the subjective night, we seldom recorded inhibitory responses (i.e., decreases in [Ca 2+ ] i ) and mostly observed excitatory responses both in the ventral and dorsal SCNs. These excitatory responses were reduced in SCN slices from Scn1a +/− mice and dramatically decreased in slices from Scn1a −/− mice. This reduced excitability may be a consequence of decreased Na V 1.1 channel activity in both neurons directly innervated by RHT glutamatergic terminals as well as neurons that respond with excitatory postsynaptic potentials to GABA release from SCN interneurons.
Our results are in line with a model in which Na V 1.1 channel activity is critical for GABAergic neuron excitability within SCN neurons. Light during the subjective night has the ability to activate ventral SCN neurons, which in turn relay this photic information to dorsal neurons through the release of GABA. Reduced Na V 1.1 channel activity in Scn1a +/− mice would impair this ventral-dorsal propagation and would reduce circadian photoresponsiveness. Because VIP neurons in the SCN are GABAergic, reduced Na V 1.1 activity would also affect the release of this neuropeptide, further contributing to a disrupted response to light and other circadian anomalies.
SMEI and the Circadian System. Circadian abnormalities in Scn1a +/− mice derive from impaired excitability of GABAergic interneurons, which was previously observed for ataxia (14) and deficits in homeostatic regulation of sleep (63) . Therefore, the comorbidities of ataxia and sleep disorders in children with SMEI may both be caused by the primary genetic defect in this disease-loss of Na V 1.1 channels and impairment of firing of GABAergic interneurons. Together, these results support a unified mechanism for epilepsy and comorbidities in SMEI. This fundamental pathological insight suggests that all of the symptoms of SMEI may be treatable by enhancement of GABAergic neurotransmission. The recovery of circadian abnormalities by a GABAergic transmissionenhancing diet is remarkable and suggests that similar therapies could be used to treat some of the sleep comorbidities present in SMEI patients. Of note, treatment with the combination of tiagabine and clonazepam is also effective in prevention of seizures in Scn1a +/− mice (64) , and therefore, this combination therapy may indeed have value in treating both primary seizures and comorbidities of SMEI.
Methods
All experiments with animals were performed according to the National Institutes of Health Guide for Care and Use of Laboratory Animals and were approved by the University of Washington Institutional Animal Care and Use Committee.
Generation of Na V 1.1 Mutant Mice. Mutant mice used in this study were generated by targeted deletion of the last exon encoding domain IV from the S3 to S6 segment and the entire C-terminal tail of Na V 1.1 channels as described previously (13) . The animals used in this study were generated by crossing heterozygous mutant males of C57BL/6 background with WT C57BL/ 6 females. Na V 1.1 null mice for calcium imaging were generated by breeding Na V 1.1 heterozygous pairs of mixed C57BL/6 and 129Sv background. Mice were genotyped as described previously (14) .
Immunoblotting, Immunohistochemistry, and in Situ Hybridization. SCN tissue was harvested by punching the SCN regions with a 16-gauge needle from 300-μm-thick brain slices. Membrane proteins were partially purified by discontinuous sucrose gradient centrifugation, fractionated by SDS/PAGE (100 μg), and immunoblotted with an anti-Na V 1.1 antibody (diluted 1:200; Chemicon) as described previously (13) .
In situ hybridization for the Na V 1.1 mRNA was performed using a digoxigenin-labeled antisense riboprobe as described before (65), with the exception that 16-μm coronal sections were cut from fresh-frozen brains. The probe was generated from an Scn1a PCR-specific product (forward primer containing T3 promoter: 5′-AATTAACCCTCACTAAAGGGCATTCAGCGAGCT-TATAGGCGCCACC-3′; reverse primer containing T7 promoter: 5′-TAATAC-GACTCACTATAGGGCACAGGCTGTAAACAATTTG TCACCCA-3′). Scn1a signal was detected using antidigoxigenin antibody (diluted 1:200; Roche). For double-labeling experiments, monoclonal anti-GAD67 (diluted 1:200; Chemicon) was added at the same time as antidigoxigenin antibody. For controls, the primary antiserum was omitted or replaced with normal rabbit serum. In situ hybridization for c-Fos, mPer1, and mPer2 was performed with radiolabeled riboprobes as previously described (65) . Autoradiographic images were generated by exposing slides to Ultramax film (Kodak). Images were scanned at high resolution, and hybridization intensities were determined with ImageJ software (National Institutes of Health) using templates for the whole SCN (Fig. 5) or the ventral and dorsal SCNs (Fig. 6 ).
Behavioral Measurements and Analysis. Adult Scn1a +/− mice and their WT littermates were housed in individual cages equipped with a running wheel and maintained in ventilated, light-tight chambers. Wheel-running activity was monitored in 10-min bins using Clocklab software (Actimetrics) and analyzed using the El Temps software (Diéz-Noguera, University of Barcelona, Barcelona, Spain). Animals were entrained to a 12:12 LD cycle (lights on 8:00 AM) with 200-lux intensity for at least 14 d before release into constant DD. Free-running period was measured using periodogram analysis (66) . To determine the light-induced phase shift of locomotor activity, animals in their home cages were moved to another chamber and exposed to a 30-min pulse of white light (500 lux) at CT16; dark-treated controls were moved but received no light treatment. Because light acutely inhibits wheel-running activity, the analysis of reentrainment rate after abrupt shifts of the LD cycles was different for advances and delays. For advances, the number of days for the onset of activity to reach its original phase relationship with the LD cycle was counted. For delays, the number of days for the offset of activity to reach its original phase relationship was counted. For all phaseshifting stimuli, no cage changes were scheduled on the days after the stimulus, because cage changes are known to induce phase shifts. Waveforms were calculated by first calculating the 10-min mean of wheel-running activity for several successive days for each animal; then, the mean ± SEM was calculated for all of the animals for each 10- (Fig. 8B) or 30-min (Fig. 2D) interval. Phase angle of entrainment was calculated by estimating the difference in minutes between the activity onset on the first day after release into DD and the extrapolated time of lights off (from the previous day) to discard the effects of negative masking by light.
ERG. ERG was performed using a Ganzfeld bowl, direct current amplifier, and PC-based control and recording system (Multiliner Vision; VIASYS Healthcare GmbH). Mice were dark-adapted overnight and anesthetized with ketamine (67 mg/kg) and xylazine (12 mg/kg). Pupils were dilated with tropicamide. Single-flash 1.5-log cd × s/m 2 stimuli were delivered under dark-adapted conditions. ERG responses were recorded under the intensity that led to maximum amplitude response in both WT and Scn1a +/− mice (1.5 log cd × s/m 2 ). Ten responses were averaged, with an interstimulus interval of 17 s.
Calcium Imaging. For [Ca 2+ ] i imaging experiments, SCN slices from P15 to P20 mice were prepared during the early subjective night (ZT14 to -15) and maintained in artificial cerebrospinal fluid containing 1.75 μM of the [Ca 2+ ] i indicator dye fluo-4 and 0.07% Pluronic-127 (Molecular Probes/Invitrogen) for 20 min as previously described (67) . After loading, the tissue was positioned in a microscope chamber and imaged on a Nikon inverted Diaphot microscope with a cooled CCD camera (Photometrics) at 3 Hz. The chamber was constantly perfused with carbogen-bubbled ACSF at a rate of 1 mL min −1 . Images and measurements were recorded using MetaFluor (Universal Statistical Analysis. Data are presented as mean ± SEM (one-or two-way ANOVA followed by Tukey or Student t contrasts for comparisons in which type I error was not possible). P < 0.05 was considered as statistically significant. Statistical analysis was done using the JMP software.
